View Single Post
Old 10-12-2005, 01:45 PM   #2
Kim in DC
Senior Member
 
Join Date: Nov 2004
Posts: 190
E75 Vaccine

I have not enrolled as of yet but I am still very interested. I am HLA A3 not A2 so I am only eligible for this vaccine.

I am currently still taking Herceptin, following the ASCO data. Although they applied to the FDA to use in concurrently with Herceptin, they are not approved yet to do both. My onc and I decided I will continue with Herceptin until the 2 year Hera data is released at Asco next May. If they allow current Herceptin users in the trial, I'm all over it!!!!!
__________________
8/98 dx right breast
5/2003 tram flap right breast
8/2004 dx new primary left breast with inflammatory bc
er/pr-, her2neu+++
8/19 taxotere and herceptin
1/15/2005 Navelbine/Herceptin
4/2005 radiation and Herceptin
5/15/2005 Herceptin alone
2/12/2008 skin biopsy positive
2/14/2008 met to sternum, possibly right breast
2/27/08 Start omitarg, herceptin, taxotere trial
3/17/08 Kicked off trial because I started too close to my last herceptin
3/19 start tykerb xeloda
Right breast confirmed met
5/15/08 skin mets gone, no hypermetabolic activity in breast, sternum healing
8/24/08 scans still look good. sternum still active with scarring. No evidence of progression
10/08 Progression in sternum
12/08 Start TDM1 trial
1/09 Scans show stable
12/09 1 year on TDM1 still stable
10/10 progression in chest and liver
11/10 false positive of liver mets; tykerb and herceptin
4/11 Tykerb/Herceptin/Xgeva
4/11 Rads to Sternum
5/12/12 NED Herceptin/Zometa
3/16/19 still NED Herceptin/Zometa very 6months
Kim in DC is offline   Reply With Quote